HLA-A, B7.1-transfected adenocarcinoma vaccine (University of Miami)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHLA-A, B7.1-transfected adenocarcinoma vaccine (University of Miami)
Drug Alias NameAd100-B7.1/HLA
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungAdenocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Miami
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Miami
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungAdenocarcinoma

Other Information

ATC CodeN/A
Related LinksN/A